The front runner's22 Jul 2022 19:45
The ERS is a leading international respiratory congress. It provides us the opportunity to share these positive data with the scientific and clinical communities and, very importantly, the congress is attended by all the major respiratory-focused pharmaceutical companies. Ultimately, we will be looking to license NXP002 and the congress offers us an important opportunity to present and introduce NXP002 to potential licensing partners."
The largest manufacturers of inhalers are GlaxoSmithKline (makers of the Advair Diskus and Flixotide), Merck (makers of Asmanex and Proventil HFA), AstraZeneca (makers of Pulmicort and Symbicort),Boehringer-Ingelheim (makers of Atrovent, Combivent, and Spiriva which are used for asthma, COPD, and emphysema).
AstraZeneca stands out of the crowd for me, it pays out a dividend that's over 400 times our current share price, there market cap is mind boggling too.
"Don't hold your breath" has no meaning here.
Have a wonderful weekend all